Traws Pharma Inc (TRAW) stock news · $12.1M cap
Traws Pharma Inc (TRAW) is a biotechnology company listed on NASDAQ.
This TRAW news page leads with what Traws Pharma Inc filed — not a scraped headline mill.
No cached 8-K sentence for TRAW yet. We will not pad this page with generic market recap.
Latest reported TRAW revenue for 2025-09-30 was $2.8M. Net income was $16.6M. Revenue was up 2.1% from 2025-06-30 to 2025-09-30. TRAW currently screens at market cap $12.1M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the TRAW stock page; for the tape open the quote page.
TRAW stock news FAQ
What are TRAW's latest revenue and net income?
Latest cached Traws Pharma Inc (TRAW) revenue for Sep 30, 2025 was $2.8M. Net income was $16.6M. Statements: https://lician.com/financials/traw
How did TRAW revenue change from the prior cached period?
Cached Traws Pharma Inc (TRAW) revenue was up 2.1% from $2.7M (Jun 30, 2025) to $2.8M (Sep 30, 2025). Statements: https://lician.com/financials/traw
What is TRAW's market cap?
Traws Pharma Inc (TRAW) market cap is $12.1M on the latest cached fundamentals snapshot.
What kind of company is TRAW?
Traws Pharma Inc (TRAW) is a biotechnology company listed on NASDAQ.
Where is TRAW stock news listed?
Cached stock news for Traws Pharma Inc (TRAW) is listed at https://lician.com/news/traw. Filings: https://lician.com/sec/traw
Not investment advice.